These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22012586)

  • 1. Selective recognition of co-assembled thrombin aptamer and docetaxel on mesoporous silica nanoparticles against tumor cell proliferation.
    Gao L; Cui Y; He Q; Yang Y; Fei J; Li J
    Chemistry; 2011 Nov; 17(47):13170-4. PubMed ID: 22012586
    [No Abstract]   [Full Text] [Related]  

  • 2. Signal-on electrochemiluminescence biosensor for thrombin based on target-induced conjunction of split aptamer fragments.
    Lin Z; Chen L; Zhu X; Qiu B; Chen G
    Chem Commun (Camb); 2010 Aug; 46(30):5563-5. PubMed ID: 20532276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate.
    Zhu CL; Lu CH; Song XY; Yang HH; Wang XR
    J Am Chem Soc; 2011 Feb; 133(5):1278-81. PubMed ID: 21214180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic sensing based on chemically induced assembly of a signaling DNA aptamer on a fluid bilayer membrane.
    Dave N; Liu J
    Chem Commun (Camb); 2012 Apr; 48(31):3718-20. PubMed ID: 22399107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targeting.
    Sá LT; Pessoa C; Meira AS; da Silva MI; Missailidis S; Santos-Oliveira R
    Oncology; 2012; 82(4):213-7. PubMed ID: 22508189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An aptamer-based assay for thrombin via structure switch based on gold nanoparticles and magnetic nanoparticles.
    Zheng J; Cheng GF; He PG; Fang YZ
    Talanta; 2010 Mar; 80(5):1868-72. PubMed ID: 20152425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
    He X; Hai L; Su J; Wang K; Wu X
    Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
    Liu Q; Zhang J; Xia W; Gu H
    Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible cell-specific drug delivery with aptamer-functionalized liposomes.
    Cao Z; Tong R; Mishra A; Xu W; Wong GC; Cheng J; Lu Y
    Angew Chem Int Ed Engl; 2009; 48(35):6494-8. PubMed ID: 19623590
    [No Abstract]   [Full Text] [Related]  

  • 10. Light- and pH-responsive release of doxorubicin from a mesoporous silica-based nanocarrier.
    Knežević NŽ; Trewyn BG; Lin VS
    Chemistry; 2011 Mar; 17(12):3338-42. PubMed ID: 21337435
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles.
    Thomas CR; Ferris DP; Lee JH; Choi E; Cho MH; Kim ES; Stoddart JF; Shin JS; Cheon J; Zink JI
    J Am Chem Soc; 2010 Aug; 132(31):10623-5. PubMed ID: 20681678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.
    Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ
    Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive optical biosensor for thrombin based on structure switching aptamer-luminescent silica nanoparticles.
    Babu E; Mareeswaran PM; Rajagopal S
    J Fluoresc; 2013 Jan; 23(1):137-46. PubMed ID: 22965479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aptamer-gated silica mesoporous material for thrombin detection.
    Oroval M; Climent E; Coll C; Eritja R; Aviñó A; Marcos MD; Sancenón F; Martínez-Máñez R; Amorós P
    Chem Commun (Camb); 2013 Jun; 49(48):5480-2. PubMed ID: 23660687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-responsive controlled release of antitumour-active polyoxometalate from mesoporous silica materials.
    Sun G; Chang Y; Li S; Li Q; Xu R; Gu J; Wang E
    Dalton Trans; 2009 Jun; (23):4481-7. PubMed ID: 19488446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles.
    He X; Zhao Y; He D; Wang K; Xu F; Tang J
    Langmuir; 2012 Sep; 28(35):12909-15. PubMed ID: 22889263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and ultra-sensitive detection of AMP using a fluorescent and magnetic nano-silica sandwich complex.
    Song Y; Zhao C; Ren J; Qu X
    Chem Commun (Camb); 2009 Apr; (15):1975-7. PubMed ID: 19333462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silica.
    Liu J; Bu W; Pan L; Shi J
    Angew Chem Int Ed Engl; 2013 Apr; 52(16):4375-9. PubMed ID: 23495013
    [No Abstract]   [Full Text] [Related]  

  • 20. Aptamer-based nanoparticles for cancer targeting.
    Sá LT; Simmons S; Missailidis S; da Silva MI; Santos-Oliveira R
    J Drug Target; 2013 May; 21(5):427-34. PubMed ID: 23350808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.